loader image

SARS-CoV-2 rS Protein Nanoparticle Vaccine [Covovax]

Regulatory Information

Date

EUA Amendment of SARS-CoV-2 Protein nanoparticle Vaccine [Covovax]

14 February 2023

Product Information

  For Vaccine Recipients and Healthcare Providers

For more information on reporting side effects, click here.

Shares